The finding by Dr. De Luca is unexpected since response-dependent changes in visual stimuli were not presented at the time when the compound was self-injected. Selfadministration of synthetic cannabinoids in most studies has been demonstrated in the presence of response-dependent changes in visual stimuli [3, [7] [8] [9] 11, 12, 14] . The Dr. De Luca's finding is important because the dopamine D2-like agonist, quinpirole, was not selfadministered above vehicle levels in experimentally naïve rats even when a responsedependent injection-paired visual stimulus was presented [18, 19] . Further, (-)-nicotine was not self-administered above vehicle levels in experimentally naïve rats in the absence of an injection-paired visual stimulus [20] . In addition, the rate of acquisition of selfadministration reported by Dr. De Luca is also unexpected: 100% of fourteen rats assessed [1] . To put this in context, maximal self-administration acquisition rates of the synthetic cannabinoid WIN 55,212-2 using drug naïve, adult rats were reported to be 85.7 % (12 out of 14) at 0.0125 mg/kg/injection [7] or 60.0% (3 out of 5) at 0.01 mg/kg/injection [3] . Finally, the finding by Dr. De Luca stands in marked contrast to the reinforcing effects of
This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Δ9-THC. Despite the demonstrated effectiveness of Δ9-THC as a positive reinforcer in experimentally naïve squirrel monkeys [21] , Δ9-THC has been reported to fail to maintain IV self-administration responding above vehicle levels in rats [2, 3] and rhesus monkeys [4] [5] [6] . Thus, it appears that JWH-018 is a more effective positive reinforcer in rats than Δ9-THC.
As mentioned above, the abuse of synthetic cannabinoids is increasing [15, 16] . Despite the low effectiveness of the phytocannabinoid Δ9-THC as a positive reinforcer in a rat species [2, 3] , Dr. De Luca found a relatively high capacity of the synthetic cannabinoid JWH-018 to induce self-administration responding above vehicle levels in experimentally naïve rats [1] . Unexpectedly, Dr. De Luca also demonstrated self-administration of the endocannabinoid 2-arachidonoylglycerol in experimentally naïve rats [22] . These findings suggest that rats will be a useful model for the further assessment of the abuse potential of various synthetic cannabinoids. 
